Sees adjusted EBITDA $3.01-$3.11B
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on BHC:
- Bausch says district court misses Norwich suit against FDA
- Denial of Norwich’s injunction motion ‘slightly positive’ for Bausch, says RBC
- Bausch Health call volume above normal and directionally bullish
- Bausch Health unveils ‘Looking Forward’ television campaign
- Bausch Health price target lowered to $8 from $9 at RBC Capital